American International Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-96,351
| Closed | -$40.3M | – | 2665 |
|
|
2024
Q1 | $40.3M | Sell |
96,351
-1,162
| -1% | -$491K | 0.14% | 66 |
|
|
2023
Q4 | $39.7M | Sell |
97,513
-224
| -0.2% | -$82.7K | 0.16% | 59 |
|
|
2023
Q3 | $34M | Buy |
97,737
+2,719
| +3% | +$951K | 0.22% | 62 |
|
|
2023
Q2 | $33.4M | Buy |
95,018
+1,240
| +1% | +$418K | 0.2% | 74 |
|
|
2023
Q1 | $29.5M | Buy |
93,778
+490
| +0.5% | +$147K | 0.19% | 83 |
|
|
2022
Q4 | $26.9M | Sell |
93,288
-5,141
| -5% | -$1.57M | 0.19% | 92 |
|
|
2022
Q3 | $28.5M | Sell |
98,429
-1,406
| -1% | -$405K | 0.21% | 74 |
|
|
2022
Q2 | $28.1M | Sell |
99,835
-3,727
| -4% | -$998K | 0.19% | 84 |
|
|
2022
Q1 | $27M | Sell |
103,562
-2,826
| -3% | -$671K | 0.15% | 107 |
|
|
2021
Q4 | $23.4M | Sell |
106,388
-2,130
| -2% | -$414K | 0.12% | 136 |
|
|
2021
Q3 | $19.7M | Sell |
108,518
-852
| -0.8% | -$166K | 0.1% | 164 |
|
|
2021
Q2 | $22.1K | Sell |
109,370
-7,944
| -7% | -$1.66M | 0.07% | 201 |
|
|
2021
Q1 | $25.2K | Sell |
117,314
-3,362
| -3% | -$738K | 0.09% | 169 |
|
|
2020
Q4 | $28.5K | Buy |
120,676
+9,938
| +9% | +$2.28M | 0.11% | 147 |
|
|
2020
Q3 | $30.1M | Sell |
110,738
-3,414
| -3% | -$942K | 0.14% | 98 |
|
|
2020
Q2 | $33.1M | Buy |
114,152
+1,924
| +2% | +$522K | 0.16% | 85 |
|
|
2020
Q1 | $26.7M | Sell |
112,228
-1,668
| -1% | -$383K | 0.15% | 88 |
|
|
2019
Q4 | $24.9M | Buy |
113,896
+5,145
| +5% | +$1.04M | 0.1% | 118 |
|
|
2019
Q3 | $18.4M | Sell |
108,751
-210
| -0.2% | -$37.1K | 0.07% | 158 |
|
|
2019
Q2 | $20M | Sell |
108,961
-7,318
| -6% | -$1.28M | 0.08% | 138 |
|
|
2019
Q1 | $21.4M | Sell |
116,279
-577
| -0.5% | -$107K | 0.08% | 127 |
|
|
2018
Q4 | $19.4M | Buy |
116,856
+296
| +0.3% | +$51.3K | 0.08% | 131 |
|
|
2018
Q3 | $22.5M | Buy |
116,560
+5,555
| +5% | +$989K | 0.07% | 131 |
|
|
2018
Q2 | $18.9M | Buy |
111,005
+284
| +0.3% | +$44K | 0.07% | 153 |
|
|
2018
Q1 | $18M | Buy |
110,721
+154
| +0.1% | +$25.2K | 0.06% | 168 |
|
|
2017
Q4 | $16.6M | Buy |
110,567
+2,325
| +2% | +$344K | 0.05% | 188 |
|
|
2017
Q3 | $16.5M | Sell |
108,242
-4,924
| -4% | -$741K | 0.06% | 171 |
|
|
2017
Q2 | $14.6M | Buy |
113,166
+1,102
| +1% | +$133K | 0.05% | 210 |
|
|
2017
Q1 | $12.3M | Buy |
112,064
+158
| +0.1% | +$13.9K | 0.04% | 273 |
|
|
2016
Q4 | $8.24M | Sell |
111,906
-1,649
| -1% | -$134K | 0.03% | 456 |
|
|
2016
Q3 | $9.9M | Buy |
113,555
+1,939
| +2% | +$183K | 0.04% | 317 |
|
|
2016
Q2 | $9.6M | Buy |
111,616
+2,753
| +3% | +$238K | 0.04% | 313 |
|
|
2016
Q1 | $8.65M | Sell |
108,863
-1,225
| -1% | -$111K | 0.03% | 433 |
|
|
2015
Q4 | $13.9M | Buy |
110,088
+2,175
| +2% | +$263K | 0.06% | 213 |
|
|
2015
Q3 | $11.2M | Sell |
107,913
-781
| -0.7% | -$100K | 0.05% | 283 |
|
|
2015
Q2 | $13.4M | Sell |
108,694
-4,994
| -4% | -$629K | 0.05% | 244 |
|
|
2015
Q1 | $13.4M | Buy |
113,688
+5,369
| +5% | +$643K | 0.06% | 253 |
|
|
2014
Q4 | $12.9M | Buy |
108,319
+2,024
| +2% | +$228K | 0.06% | 231 |
|
|
2014
Q3 | $11.9M | Buy |
106,295
+2,307
| +2% | +$220K | 0.05% | 252 |
|
|
2014
Q2 | $9.85M | Buy |
103,988
+10,080
| +11% | +$707K | 0.04% | 360 |
|
|
2014
Q1 | $6.64M | Buy |
93,908
+420
| +0.4% | +$33.3K | 0.03% | 555 |
|
|
2013
Q4 | $6.95M | Sell |
93,488
-78
| -0.1% | -$5.43K | 0.03% | 503 |
|
|
2013
Q3 | $7.09M | Sell |
93,566
-381,905
| -80% | -$30.4M | 0.04% | 462 |
|
|
2013
Q2 | $38M | Buy |
+475,471
| New | +$35M | 0.23% | 60 |
|
Other funds holding VRTX
American International Group's VRTX Position: Q2 2024 in Review
American International Group sold out of Vertex Pharmaceuticals (VRTX) in Q2 2024, closing a stake of 96,351 shares — an estimated $40.3M sold.
American International Group first reported a position in VRTX in Q2 2013 and held it in 44 quarters. The position peaked at $40.3M in Q1 2024. 1,546 funds tracked by Wall St. Rank hold VRTX as of Q2 2024.
- American International Group reported no remaining Vertex Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
- American International Group sold 96,351 Vertex Pharmaceuticals shares in Q2 2024, an estimated $40.3M.
- American International Group first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 44 quarters.
- American International Group's Vertex Pharmaceuticals position peaked at $40.3M in Q1 2024.
- 1,546 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2024.
Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.